Highlights from CGT Summit 2024: Accelerating Innovation in Cell & Gene Therapy

The inaugural Global Cell & Gene Therapy Summit (CGT Summit 2024) took place from July 8–10, 2024, at the Boston Marriott Newton Hotel, drawing over 300 attendees from leading universities, biotech companies, CDMOs, regulatory bodies, and clinical institutions. The event served as a dynamic forum to explore the full scope of breakthroughs, challenges, and partnerships shaping the future of cell and gene therapy (CGT).

Program Overview

CGT Summit 2024 was structured around three core days:

• Day 1: Scientific Advancements in CGT
  Topics included stem cell-based therapies, CAR-T and TCR-T innovations, and gene therapy methods advancing toward clinical applications.
• Day 2: Manufacturing and Translational Progress
  Discussions focused on CGT manufacturing scale-up, AAV engineering, process optimization, and quality control, concluding with a panel on affordability and innovation in viral vector production.
• Day 3: Regulatory and Commercialization Outlook
  Featured deep dives into regulatory strategies, collaborative industry-academic models, and global commercialization challenges.

Speaker Highlights

The 2024 summit hosted more than 60 distinguished speakers. Key highlights included:

• Keynote Addresses from Prof. Alan M. Lambowitz (UT Austin), Prof. Rudolf Jaenisch (MIT), and Dr. Ula V. Jurkunas (Harvard Medical School), addressing RNA technologies, stem cell biology, and translational ophthalmology.
• Thought Leaders like Amir Hefni (CEO, Resolution Therapeutics), Erin Kimbrel (President, Astellas Institute for Regenerative Medicine), Rachel Salzman (CEO, Armatus Bio), Jerome Chal (SVP, Myeloid Therapeutics), and Jason Criscione (CSO, Enquyst Technologies) delivered impactful presentations on CGT platforms, regulatory strategy, and therapeutic translation.

Exhibitor Showcase

The exhibition space brought together a strong lineup of solution providers, offering hands-on insights into the tools and platforms driving CGT innovation:

• Envoya Inc.
• Chemometec
• Zerogravityskin
• CRISPR QC
• Enrich Biosystem
• SGS
• Thermo fisher Scientific

These exhibitors demonstrated cutting-edge technologies in analytics, cell processing, gene editing, and regulatory support.

Networking & Collaboration

The summit fostered a collaborative atmosphere through:

• Poster presentations and informal receptions
• One-on-one discussions with speakers and exhibitors
• Themed panels and fireside chats
• A community networking dinner that enabled new partnerships and collaborations 

Conclusion

CGT Summit 2024 delivered a strong foundation for an ongoing global dialogue around scientific discovery, clinical advancement, and scalable commercialization in CGT. The exchange of ideas and actionable insights left attendees inspired and ready to take the next steps in advancing breakthrough therapies.

We extend sincere thanks to all speakers, sponsors, and participants. The energy and momentum generated in Boston set the stage for an even more impactful gathering in 2025 and beyond.